Does TRILACICLIB Cause Haemorrhage? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Haemorrhage have been filed in association with TRILACICLIB (COSELA). This represents 4.9% of all adverse event reports for TRILACICLIB.
11
Reports of Haemorrhage with TRILACICLIB
4.9%
of all TRILACICLIB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Haemorrhage From TRILACICLIB?
Of the 11 reports, 11 (100.0%) required hospitalization.
Is Haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRILACICLIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TRILACICLIB Cause?
Off label use (25)
Myelosuppression (24)
Dyspnoea (18)
Pneumonia (18)
White blood cell count decreased (18)
Platelet count decreased (17)
Anaemia (15)
Performance status decreased (14)
Death (13)
Infection (12)
What Other Drugs Cause Haemorrhage?
RIVAROXABAN (6,571)
APIXABAN (4,770)
EMICIZUMAB-KXWH (3,612)
WARFARIN (2,930)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (2,925)
ASPIRIN (2,878)
ADALIMUMAB (2,681)
IBRUTINIB (1,907)
CLOPIDOGREL BISULFATE (1,762)
INSULIN LISPRO (1,614)
Which TRILACICLIB Alternatives Have Lower Haemorrhage Risk?
TRILACICLIB vs TRILEPTAL
TRILACICLIB vs TRIMEBUTINE
TRILACICLIB vs TRIMEPRAZINE
TRILACICLIB vs TRIMETAZIDINE
TRILACICLIB vs TRIMETHOBENZAMIDE